A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David K Scales, MD
Foresight Studies, LLC
Principal Investigator - David S. Chu, MD
Metropolitan Eye Research and Surgery Institute
Principal Investigator - Quan D Nguyen, MD, MSc
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Byers Eye Institute, Stanford University
Palo Alto, California, United States
Recruiting - Metropolitan Eye Research and Surgery Institute
Palisades Park, New Jersey, United States
Recruiting - Foresight Studies, Llc
San Antonio, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2019
- Primary completion
- 8 Dec 2024
- Completion
- 8 Dec 2024
- Last update posted
- 23 Oct 2023
- Registered enrollment
- 30
- Registry id
- NCT03465111
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.